Czech National Bank boosted its stake in Cigna Group (NYSE:CI – Free Report) by 3.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 70,437 shares of the health services provider’s stock after buying an additional 2,642 shares during the period. Czech National Bank’s holdings in Cigna Group were worth $19,386,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Norges Bank bought a new stake in shares of Cigna Group during the 2nd quarter worth about $1,110,426,000. Capital Research Global Investors boosted its holdings in shares of Cigna Group by 140.2% in the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after acquiring an additional 1,855,897 shares in the last quarter. Ameriprise Financial Inc. increased its stake in shares of Cigna Group by 54.5% during the third quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after acquiring an additional 753,865 shares during the period. Arrowstreet Capital Limited Partnership increased its stake in shares of Cigna Group by 24.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after acquiring an additional 492,045 shares during the period. Finally, Balyasny Asset Management L.P. raised its holdings in Cigna Group by 1,057.2% during the second quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after purchasing an additional 369,775 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
Insider Buying and Selling at Cigna Group
In other news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.60% of the company’s stock.
Cigna Group Stock Performance
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. During the same quarter in the prior year, the firm earned $6.64 EPS. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities research analysts predict that Cigna Group will post 29.77 EPS for the current year.
Cigna Group Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th were given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend was Thursday, March 5th. Cigna Group’s payout ratio is 28.13%.
Analyst Ratings Changes
A number of equities analysts have issued reports on CI shares. Zacks Research raised Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Barclays cut their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a report on Friday, February 6th. Truist Financial raised their target price on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a report on Tuesday, February 10th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $333.11.
Get Our Latest Stock Report on CI
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Stories
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
